Bruker Corporation to Present at Investor Conferences
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
10th Annual SVB Leerink Healthcare Conference
Thursday, February 25, 2021, at 8:40 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer
Cowen 41st Annual Health Care Conference
Tuesday, March 2, 2021, at 11:10 a.m. Eastern Time
Gerald Herman, Chief Financial Officer
Live audio webcasts of the virtual “fireside chat” sessions will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays will be posted on Bruker’s Investor Relations website after each event and will be available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
Director, Investor Relations & Corporate Development
T: +1 (978) 663 – 3660, ext. 1479
Source: Bruker Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Autobahn Therapeutics Presents Preclinical, Proof of Concept Data for ABX-002 for the Treatment of Adrenomyeloneuropathy
- One Voice Children's Choir Uses Their Voices to Raise Awareness of Their Nonprofit with "Little Voice"
- ClassWorx Interview with Agro Capital Management Corp CEO Scott Benson Now Available on Youtube